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 Abstract 
Bacterial type I toxin-antitoxin systems consist of stable toxin-encoding mRNAs whose expression 
is counteracted by unstable RNA antitoxins. Accumulating evidence suggests that these players 
belong to broad regulatory networks influencing overall bacterial physiology. The majority of 
known transmembrane type I toxic peptides have conserved structural characteristics. However, 
recent studies demonstrated that their mechanisms of toxicity are diverse and complex. To better 
assess the current state of the art, type I toxins can be grouped into two classes according to their 
location and mechanisms of action: membrane-associated toxins acting by pore formation and/or 
by nucleoid condensation; and cytosolic toxins inducing nucleic acid cleavage. This classification 
will evolve as a result of future investigations. 
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1- Introduction 1 
Toxin-antitoxin (TA) systems are widespread in bacterial and archaeal genomes. In these 2 
systems, the expression of a stable toxin-encoding messenger RNA (mRNA) leads to stasis or cell 3 
death unless an unstable antitoxin counteracts its effects. TA systems were first identified on 4 
plasmids, where they ensure plasmid maintenance through post-segregational killing (PSK) 5 
mechanisms [1]. TA systems were later identified on chromosomes, sometimes in multiple copies, 6 
and on phage-like elements. Although in many cases their functions are unknown, they are 7 
involved in programmed cell death, bacterial growth control, defense against the intrusion of 8 
foreign genetic material, and persistence [2]. TAs are classified into five types according to the 9 
antitoxin’s nature and mechanisms of action. Here, we focus exclusively on type I TA systems, 10 
characterized by RNA antitoxins that inhibit toxic peptide synthesis [1]. For the four other types, 11 
please refer to the review by Goeders and Van Melderen [3]. 12 
 13 
Type I TA loci can be transmitted by vertical gene transfer or in specific lineages by gene 14 
duplications [4]. RNA antitoxins can act in cis or in trans. The majority of the type I antitoxins 15 
identified so far are cis-acting antitoxins (e.g., Sib and SprF1 antitoxins [5,6●]), meaning that they 16 
overlap and perfectly match the toxin-encoding mRNA. The trans-acting antitoxins (e.g., IstR1 and 17 
OhsC [5]) are located away from the toxin locus and share often limited sequence 18 
complementarities. An exception to this in which a RNA antitoxin controls toxin translation via its 19 
non-overlapping sequence was recently described in Staphylococcus aureus [7]. TA RNA duplex 20 
formation can either result in toxin mRNA degradation (e.g., RatA [8]) or, more commonly, result in 21 
toxin translation inhibition (e.g., IstR1 [9]), or in the combination of the two regulatory mechanisms 22 
(e.g., SR4 [10] and SprF1 [6●]) [11]. 23 
Most type I toxins identified to date have conserved structural features: they generally contain less 24 
than 60 amino acids are hydrophobic and have a putative α-helical transmembrane domain, 25 
except for SymE and RalR [12,13●]. Despite these similarities, the biological functions and 26 
mechanisms of action of type I toxins can be very diverse. Therefore, inspired by Jahn and 27 
collaborators [14●●], type I TA systems were cataloged in this review based on the toxins’ 28 
currently-known mechanisms of action, and are summarized here in Table 1. Many studies 29 
reporting type I toxin functions were based upon episomal overproduction, and deletion of the 30 
modules was not often associated with a phenotype. For this reason, it remains difficult to 31 
distinguish between the primary and secondary molecular targets of type I toxins. 32 
 33 
1/ Membrane-associated type I toxins 34 
Some membrane-associated type I toxins have been reported to disrupt membrane integrity 35 
through pore formation or via nucleoid condensation. However, for many type I toxins, either no, or 36 
only one of these mechanisms has been investigated experimentally. 37 
a- Peptides inducing membrane permeation through pore-formation 38 
Some type I toxins, similar to the phage holin proteins, are membrane-associated peptides that 39 
form pores, resulting in a drop in potential and ATP synthesis. Thus, their overexpression leads to 40 
cell death, evidenced by the appearance of “ghost” cells with translucent centers and cell material 41 
located at the poles. However, in physiological conditions, these pore-forming peptides are 42 
involved in diverse biological functions (see the summary in Figure 1). 43 
The Hok toxic peptide in Escherichia coli, expressed from the hok/sok (or parB) locus of the R1 44 
plasmid [1], is an example of pore-forming peptide. It was the first type I TA system discovered on 45 
plasmids that confers their maintenance by PSK [15]. hok/sok homologs were identified in the 46 
chromosomes of Gram-negative bacteria, suggesting their involvement in other functions [37,38]. 47 
In response to nutrient starvation, the stringent response alarmone (p)ppGpp interacts with Obg 48 
GTPase, resulting in the induction of the hokB toxin-encoding mRNA through an unknown 49 
mechanism [16●●]. This moderateoverexpression leads to membrane depolarization responsible 50 
for a switch to a persistent state. Persister cells are a bacterial subpopulation that enters into a 51 
dormant state and thus becomes tolerant to antibiotics. While the deletion of hokB locus has no 52 
effect on persistence, possibly due to system redundancies, the overexpression of hokB mRNA is 53 
essential for Obg-mediated persistence. Another recent study [17●] has demonstrated the 54 
involvement of the hok/sok locus in bacterial lag phase expansion. This allows cells to adapt to 55 
unfavorable conditions such as elevated temperatures or the presence of antibiotics. In low cell 56 
density cultures, the system favors bacterial survival regardless of growth-limiting conditions and 57 
could complement existing or defective SOS response mechanism, an inducible DNA repair 58 
system [17●]. However, in E. coli, some of the hok/sok copies can be inactivated by insertion 59 
sequences [38]. 60 
TisB translated from the “tisB-istR1” locus is another pore-forming peptide. The TisB toxic peptide 61 
is small, hydrophobic, and spontaneously binds membranes [39]. Chemically-synthesized TisB 62 
peptides are assembled as stable transmembrane dimers. The charges on the amphiphilic TisB 63 
helix suggest that antiparallel dimers could be assembled by salt bridges, and these narrow 64 
channels could enable protons to pass across the hydrophobic membranes. Another study [20] 65 
revealed that the positively-charged TisB pores induce selective membrane permeation for 66 
hydroxyl anions. In turn, protons and anions passages dissipate the proton motive force (PMF). 67 
The TisB pore is so narrow that it is impermeable to intracellular water-soluble components, 68 
allowing cell survival. As a consequence, tisB mRNA overexpression causes a drop in ATP levels 69 
and an increase of cell death even though in physiological conditions it induces a drop in the PMF 70 
and the formation of persister cells [20]. By triggering a dormant state, TisB leads to the shutdown 71 
of the major antibiotic targets and induces multidrug tolerance (e.g., in β-lactams targeting 72 
peptidoglycan synthesis, in aminoglycosides inhibiting translation, and in ciprofloxacin reducing 73 
DNA replication by inhibiting topoisomerase activity). This phenotype has only been observed in 74 
exponentially-growing E. coli cells, corresponding to a higher expression of the genes involved in 75 
the SOS response [19]. Persister formation by the SOS-induced TisB toxin involves two strategies 76 
for survival: DNA repair activation; and entrance into a dormant state [19]. 77 
 78 
b- Peptides inducing nucleoid condensation 79 
The par locus, or the RNAI-RNAII TA system (see Figure 2), is expressed from the pAD1 plasmid 80 
of Enterococcus faecalis and encodes the Fst toxin. The par homologs have been detected in low 81 
GC Gram-positive bacteria [22]. The Fst toxic peptide possesses a hydrophobic transmembrane 82 
domain that is essential for toxicity and conserved within the Fst/Ldr superfamily. This is followed 83 
by an unstructured C-terminal tail, probably located in the cytoplasm [22]. Studies focusing on fst 84 
mRNA overexpression have shown short- and long-term effects of the toxin. Firstly, fst mRNA 85 
overexpression causes an abnormal nucleoid condensation in E. faecalis, S. aureus, Bacillus 86 
subtilis, and E. coli. Alteration of peptidoglycan synthesis, cell division and septum placements 87 
were also described in E. faecalis and B. subtilis, resulting in unequal DNA distribution among 88 
daughter cells [23,40]. While the early effects of fst toxin-encoding mRNA overexpression are at 89 
the chromosomal level, its major impact is the membrane stress that induces the transcription of 90 
numerous target genes [23]. The majority of these targeted transcripts encode membrane-91 
associated proteins. These proteins include ABC transporters such as glucan, manganese, and 92 
glycine-betaine family transporters which are associated with resistance to numerous antibiotics 93 
[41]. Transporter overexpression is harmful to the bacteria, probably through depletion of the 94 
cellular ATP pool and/or perturbed membrane integrity, as the Fst-induced responses are diverse 95 
and nonspecific. This late expression of the transporters may be a response to the Fst-induced 96 
chromosomal structure impairment. fst toxin-encoding mRNA overexpression also induces cell 97 
membrane permeation, without “ghost” cell formation, and the arrest of macromolecular synthesis 98 
[42]. RNAI-RNAII is the only type I PSK system described so far in Gram-positive bacteria [23], 99 
although numerous par homologs have been detected in many bacterial chromosomes [22]. 100 
Interestingly, overexpression of the fst-Sm/srSm TA system in Streptococcus mutans causes a 101 
significant decrease in the number of persister cells [34]. Moreover, in the opportunistic pathogen 102 
E. faecalis, a link was recently identified between the expression of a par homolog and virulence 103 
[43●●]. The mutant lacking the par homolog is more virulent in insect and mouse models, more 104 
efficiently colonizes mouse organs, and survives better inside macrophages and upon oxidative 105 
stress. The authors suggest that these effects could be involved in the transition from 106 
commensalism to virulence [34,43●●]. 107 
In E. coli, overproduction of the LdrD protein, which belongs to the Fst/Ldr superfamily [4], leads to 108 
nucleoid condensation [25], suggesting a conserved mechanism of action. Additionally, microarray 109 
analysis suggests that overexpression of ldrD mRNA upregulates genes involved in the purine 110 
metabolism pathway, and reduces cAMP levels [25]. Interestingly, overexpression of the ldrD 111 
mRNA homolog ldrA inhibits ATP synthesis and consequently DNA replication, transcription, and 112 
translation, eventually inducing cell growth arrest [44]. 113 
The E. coli DinQ toxic peptide is a small transmembrane peptide located in the inner membrane. 114 
Its expression is controlled by AgrB antisense RNA and the repressor LexA which downregulates 115 
numerous genes involved in the SOS response [45]. Ectopic overexpression of dinQ mRNA 116 
induces membrane depolarization [21]. In an agrB mutant strain, two-fold constitutive 117 
overexpression of dinQ mRNA leads to an increase in UV sensitivity associated with a decrease in 118 
intracellular ATP and a delay in nucleoid decompaction and extension after UV irradiation. 119 
Moreover, elevated levels of dinQ mRNA in this mutant have a role in the repair of UV-induced 120 
DNA damage through inhibition of conjugal recombination [21]. Thus, the DinQ toxin uses several 121 
mechanisms to modulate the E. coli UV response. 122 
Temperature-sensitive bsrG/SR4 system located within the SPβ prophage in B. subtilis is probably 123 
involved in prophage maintenance within the bacterial chromosome. Indeed, overexpressed bsrG 124 
mRNA leads to the accumulation of toxic peptides that inhibit cell growth by targeting the 125 
cytoplasmic membrane [26]. Nevertheless, bsrG mRNA overexpression interferes neither with 126 
membrane permeability nor with energy supply [14●●]. bsrG mRNA overexpression stimulates 127 
fatty acid biosynthesis, which induces invaginations of the cytoplasmic membrane, leading to 128 
abnormal membrane topology, distorted cell division planes, and a reduced cell size. This also 129 
results in a delocalization of the cell wall synthesis machinery, including the cytoskeletal 130 
component MreB normally associated to the membrane and oriented perpendicularly to the longer 131 
cell axis. With the assistance of autolytic enzymes, this disturbance of cell wall synthesis 132 
machinery leads to cell lysis. Moreover, BsrG toxin induces nucleoid condensation but 133 
chromosome segregation and replication are not affected. The nucleoid condensation, in turn, 134 
induces a significant global inhibition of transcription and translation [14●●]. 135 
c- Membrane-associated peptides with a mechanism to determined 136 
There are many other membrane-associated type I toxins with the mechanism of action still to be 137 
determined (see Table 1). For many systems, the mechanism was not addressed. For the others, 138 
information to classify toxins according to their mechanisms of action is insufficient. 139 
Among them, in the human pathogen S. aureus, two type I TA systems are located within a 140 
pathogenicity island (PI) and express membrane toxic peptides whose overexpression causes 141 
bacterial cell death. PepA1, translated from the “sprA1/sprA1AS” locus, is induced upon acidic and 142 
oxidative stresses [46]. PepG131 and PepG144 are both translated from the “sprG1/sprF1” locus. 143 
Extracellular addition of either the three chemically-synthesized peptides or of membrane extracts 144 
prepared from S. aureus cells overexpressing PepG144 and PepG131 will trigger the lysis of both 145 
competing bacteria and human erythrocytes [6●,7]. NMR structures and dynamic simulations 146 
indicate that synthetic PepA1 possesses an α-helical structure and can insert into the membrane. 147 
These toxic peptides probably damage bacterial membranes and erythrocytes through pore-148 
formation, membrane disruption due to a detergent-like effect, or by interference with membrane-149 
associated functions, nevertheless we cannot exclude a role of these toxins in nucleoid 150 
condensation [46].  151 
 152 
2/ Cytoplasmic type I toxins that cleave nucleic acids 153 
While a large number of membrane-associated type I toxins have been described, the only 154 
reported to be located in the cytoplasm have been SymE and RalR. Contrary to the other type I 155 
toxins, SymE and RalR lack putative transmembrane segments and cleave nucleic acids. 156 
 157 
a- RNA cleavage 158 
SymE is a 113-amino acid peptide that, like the MazE type II antitoxin, contains an AbrB [47]. 159 
SymE and its homologs constitute a distinct family within the AbrB superfamily. Indeed, all of the 160 
other AbrB family members are transcription factors acting as antitoxins, while the SymE 161 
homologs have become toxic proteins. SymE toxin synthesis is downregulated additively at 162 
multiple levels: at the transcriptional level by LexA; at the mRNA stability level by the cis-encoded 163 
SymR antitoxin RNA and at the translational level by SymR and Lon proteases [12]. In E. coli, the 164 
SymE protein co-purifies with ribosomal proteins, and its overexpression drastically affects colony-165 
forming ability and protein synthesis [12]. Overexpression of symE mRNA decreases levels of all 166 
tested mRNAs and regulatory RNAs except its antitoxin SymR. Moreover, after symE mRNA 167 
induction, distinct shorter mRNA fragments were observed. These results suggest that SymE acts 168 
as an endoribonuclease and cleaves mRNAs that should not be translated [12,48]. The DNA 169 
damaging agent mitomycin C induces overexpression of symE mRNA at both the mRNA and 170 
protein levels, suggesting a role for SymE toxin in simultaneously recycling damaged RNAs and 171 
DNAs during the SOS response. 172 
 173 
b- DNA cleavage 174 
The “ralR/ralA” locus is located on the E. coli rac prophage. ralR mRNA encodes a 64-amino acid 175 
type I toxin, and its overexpression leads to cell growth inhibition, while the RalA antitoxin requires 176 
the Hfq chaperone to stabilize it [13●]. In vitro DNA cleavage assays have shown that purified 177 
RalR toxin is a non-specific endonuclease that cleaves methylated or non-methylated DNAs. 178 
Furthermore, in vitro RNA cleavage assays do not reveal any RNA-targeting cleavage activity. 179 
Finally, overproduction of ralR mRNA causes a filamentous growth resulting from the SOS 180 
response following DNA degradation. The positive effects of the ralR/RalA TA system on cell 181 
physiology and fosfomycin resistance were confirmed through monitoring the growth and 182 
metabolic activity of wild-type and ralR/ralA knockout strains in the presence of fosfomycin, an 183 
inhibitor of bacterial cell wall biogenesis [13●]. 184 
 185 
2- Concluding remarks and perspectives 186 
When examined together, the effects of some type I toxins on bacterial physiology challenge the 187 
concept that membrane-associated type I toxins act solely by pore formation. This is why we 188 
propose an updated nomenclature with two classes of type I toxins. These classes are based on 189 
peptide location and their mechanisms of action: (i) membrane-associated toxins act either by 190 
pore formation and/or nucleoid condensation; and (ii) cytoplasmic toxins that catalyze nucleic acid 191 
cleavages. Table 1 summarizes the type I toxins according to the current understanding of their 192 
mechanisms of actions, and underlines the two different classes. Our nomenclature only includes 193 
the modes of action that are currently well-described, and will thus evolve based on future 194 
discoveries, but it provides a solid basis for better understanding of the TA systems. In particular, it 195 
would be appropriate to investigate whether, like many other antibacterial peptides, certain type I 196 
toxic peptides could induce a membrane disruption via the “carpet” mechanism (where peptides 197 
bind to the surface of the membrane and provoke a detergent-like effect) [49]. Moreover, the effect 198 
of the pore-forming peptides on the nucleoid condensation is usually left unexplored, so it is 199 
tempting to speculate that some may act through both mechanisms. Another important challenge 200 
would be to determine whether there is heterogeneity in toxin expression within a cell population, 201 
along with an exploration of the various triggers and signaling pathways that induce toxin 202 
expression. New hypotheses about the biological functions of toxic peptides will arise from a better 203 
understanding of their mechanisms and the identification of their molecular targets. Finally, TA 204 
systems should be considered as tiny modules embedded in larger regulatory networks where all 205 
of the different players interact. Indeed, recent discoveries implying crosstalk between type I and II 206 
TAs [50] suggest that numerous interactions involving different TA systems are yet to be 207 
discovered. 208 
The unique characteristics of TA loci make them of particular interest for biotechnological 209 
applications. TAs can be considered lead compounds for the design of new antimicrobials, 210 
plasmid maintenance tools, vaccines, and selective reporter genes [51,52]. Moreover, toxins on 211 
their own can also have various applications. Indeed, selective cloning vectors containing variants 212 
of IbsC, a type I E. coli toxic peptide, have been engineered [53]. In addition, chemical 213 
modifications of PepA1 toxin dramatically increased its antibacterial potential and its stability in 214 
human serum while considerably reducing its human cell toxicity, implying that toxins can be 215 
transformed into potent antibiotics [27]. The DinQ toxin is another promising candidate for the 216 
development of anti-cell-envelope antibiotics, notably against E. coli infection [54]. These 217 
strategies could be applied to other toxic peptides, notably for the design of new antibiotics, thus 218 
providing alternatives to the burgeoning issue of bacterial resistance to the drugs presently in use. 219 
Figure captions 220 
 221 
Table 1: Overview of the type I TA classes based on the mechanisms of action of toxins. 222 
 223 
Figure 1: Reported functions for type I pore-forming toxins. 224 
Some type I toxins expressed in response to stresses (yellow lightning) or after plasmid loss (dark 225 
grey) are located within membranes (grey), where they form pores. These pores decrease the 226 
membrane potential, cell energy levels and proton motive force (PMF), eventually leading to cell 227 
growth arrest or cell lysis of a population fraction. Plasmid maintenance, persistence, and stress 228 
adaptation were among the biological functions identified for type I pore-forming toxins located in 229 
the membrane.  230 
 231 
Figure 2: Fst toxin: an example of a “domino effect” post-segregational killing (PSK). 232 
Within E. faecalis, PSK bacterial maintenance of the pAD1 plasmid (dark grey) involves the par 233 
locus. After bacterial division, RNAI toxin mRNA and RNAII antitoxin are both expressed within the 234 
daughter cells carrying the plasmid (at left). They can form a stable RNA duplex that prevents 235 
toxin mRNA translation without effecting bacterial growth. Within the daughter cells lacking 236 
plasmids (at right), the unstable RNAII antitoxin is degraded and does not downregulate RNAI 237 
toxin translation. The toxic peptide is expressed, migrates, and accumulates at the membrane. 238 
After 15 minutes, this induces an aberrant nucleoid condensation, altered synthesis of 239 
peptidoglycan, abnormal cell division and septum placement, resulting in unequal DNA distribution 240 
among the daughter cells. After 60 minutes, probably in response to these initial triggers, Fst toxin 241 
induces transcription of numerous target genes including transporters, and results finally in cell 242 
death [23],[42]. 243 
Acknowledgments 
The authors acknowledge financial support from Universities of Rennes 1 (France), Bern 
(Switzerland), and Sherbrooke (Canada, grant ‘Fonds de recherche Nature et Technologie de 
Québec’), as well as from the French institutes, the ‘Institut National de la Santé et de la 
Recherche Médicale’ (INSERM) the School of Pharmacy and Medical Sciences of Rennes 1 
University , and the French Medical Research Foundation (FRM). We also thank P. Bouloc, Y. 
Augagneur, G. Pascreau, and M. Sassi from our lab and J. Berland for proof reading the review. 
References 
 
1. Gerdes K, Rasmussen PB, Molin S: Unique type of plasmid maintenance function: postsegregational killing of 
plasmid-free cells. Proceedings of the National Academy of Sciences of the United States of America 1986, 
83:3116-3120. 
2. Brantl S, Jahn N: sRNAs in bacterial type I and type III toxin-antitoxin systems. FEMS microbiology reviews 2015, 
39:413-427. 
3. Goeders N, Van Melderen L: Toxin-antitoxin systems as multilevel interaction systems. Toxins 2014, 6:304-324. 
4. Fozo EM, Makarova KS, Shabalina SA, Yutin N, Koonin EV, Storz G: Abundance of type I toxin-antitoxin systems in 
bacteria: searches for new candidates and discovery of novel families. Nucleic acids research 2010, 
38:3743-3759. 
5. Fozo EM, Kawano M, Fontaine F, Kaya Y, Mendieta KS, Jones KL, Ocampo A, Rudd KE, Storz G: Repression of small 
toxic protein synthesis by the Sib and OhsC small RNAs. Molecular microbiology 2008, 70:1076-1093. 
6●. Pinel-Marie ML, Brielle R, Felden B: Dual toxic-peptide-coding Staphylococcus aureus RNA under antisense 
regulation targets host cells and bacterial rivals unequally. Cell reports 2014, 7:424-435.  
This study have identified an unconventional type I toxin-antitoxin system expressed from a human 
pathogen. In this TAs, toxin expresses two hemolytic and antibacterial peptides from a dual-coding RNA, 
unless its dual-acting antisense RNA inhibits it. 
7. Sayed N, Jousselin A, Felden B: A cis-antisense RNA acts in trans in Staphylococcus aureus to control translation 
of a human cytolytic peptide. Nature structural & molecular biology 2012, 19:105-112. 
8. Silvaggi JM, Perkins JB, Losick R: Small untranslated RNA antitoxin in Bacillus subtilis. Journal of bacteriology 
2005, 187:6641-6650. 
9. Darfeuille F, Unoson C, Vogel J, Wagner EG: An antisense RNA inhibits translation by competing with standby 
ribosomes. Molecular cell 2007, 26:381-392. 
10. Jahn N, Brantl S: One antitoxin-two functions: SR4 controls toxin mRNA decay and translation. Nucleic acids 
research 2013, 41:9870-9880. 
11. Wen J, Fozo EM: sRNA antitoxins: more than one way to repress a toxin. Toxins 2014, 6:2310-2335. 
12. Kawano M, Aravind L, Storz G: An antisense RNA controls synthesis of an SOS-induced toxin evolved from an 
antitoxin. Molecular microbiology 2007, 64:738-754. 
13●. Guo Y, Quiroga C, Chen Q, McAnulty MJ, Benedik MJ, Wood TK, Wang X: RalR (a DNase) and RalA (a small RNA) 
form a type I toxin-antitoxin system in Escherichia coli. Nucleic acids research 2014, 42:6448-6462. 
This report describes a toxin-antitoxin system in which the toxin acts as a non-specific 
endodesoxiribonuclease. 
14●●. Jahn N, Brantl S, Strahl H: Against the mainstream: the membrane-associated type I toxin BsrG from Bacillus 
subtilis interferes with cell envelope biosynthesis without increasing membrane permeability. Molecular 
microbiology 2015.  
Most type I toxins are small hydrophobic membrane peptides and are assumed to target cytoplasmic 
membrane and, as a result, to induce cell death. The srG/SR4 Toxin-antitoxin module does not dissipate 
membrane potential nor affects cellular ATP-levels but strongly interferes with the envelope biosynthesis, 
causing membrane invaginations and triggering autolysis.  
15. Gerdes K, Bech FW, Jorgensen ST, Lobner-Olesen A, Rasmussen PB, Atlung T, Boe L, Karlstrom O, Molin S, von
Meyenburg K: Mechanism of postsegregational killing by the hok gene product of the parB system of 
plasmid R1 and its homology with the relF gene product of the E. coli relB operon. The EMBO journal 1986, 
5:2023-2029. 
16●●. Verstraeten N, Knapen WJ, Kint CI, Liebens V, Van den Bergh B, Dewachter L, Michiels JE, Fu Q, David CC, 
Fierro AC, et al.: Obg and Membrane Depolarization Are Part of a Microbial Bet-Hedging Strategy that 
Leads to Antibiotic Tolerance. Molecular cell 2015, 59:9-21. 
A universally conserved GTPase induces bacterial multidrug tolerance at single-cell level by transcriptional 
activation of a type I toxin. The peptide, encoded by a type I toxin-antitoxin module, provokes a collapse in 
the membrane potential, which ultimately results in bacterial persistence state. These findings are an 
important step toward unraveling shared genetic mechanisms underlying persistence.  
17●. Chukwudi CU, Good L: The role of the hok/sok locus in bacterial response to stressful growth conditions. 
Microbial pathogenesis 2015, 79:70-79.
This study showed that the hok/sok locus prolonges the bacterial lag phase in unfavorable conditions to 
enabling the cells to adapt to the stress such as high temperature and antibiotic.  
18. Vogel J, Argaman L, Wagner EG, Altuvia S: The small RNA IstR inhibits synthesis of an SOS-induced toxic peptide.
Current biology : CB 2004, 14:2271-2276. 
19. Dorr T, Vulic M, Lewis K: Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli.
PLoS biology 2010, 8:e1000317. 
20. Gurnev PA, Ortenberg R, Dorr T, Lewis K, Bezrukov SM: Persister-promoting bacterial toxin TisB produces anion-
selective pores in planar lipid bilayers. FEBS letters 2012, 586:2529-2534. 
21. Weel-Sneve R, Kristiansen KI, Odsbu I, Dalhus B, Booth J, Rognes T, Skarstad K, Bjoras M: Single transmembrane
peptide DinQ modulates membrane-dependent activities. PLoS genetics 2013, 9:e1003260. 
22. Weaver KE, Reddy SG, Brinkman CL, Patel S, Bayles KW, Endres JL: Identification and characterization of a family
of toxin-antitoxin systems related to the Enterococcus faecalis plasmid pAD1 par addiction module. 
Microbiology 2009, 155:2930-2940. 
23. Brinkman CL, Bumgarner R, Kittichotirat W, Dunman PM, Kuechenmeister LJ, Weaver KE: Characterization of the
effects of an rpoC mutation that confers resistance to the Fst peptide toxin-antitoxin system toxin. Journal 
of bacteriology 2013, 195:156-166. 
24. Rudd KE: Novel intergenic repeats of Escherichia coli K-12. Research in microbiology 1999, 150:653-664.
25. Kawano M, Oshima T, Kasai H, Mori H: Molecular characterization of long direct repeat (LDR) sequences
expressing a stable mRNA encoding for a 35-amino-acid cell-killing peptide and a cis-encoded small 
antisense RNA in Escherichia coli. Molecular microbiology 2002, 45:333-349. 
26. Jahn N, Preis H, Wiedemann C, Brantl S: bsrG/SR4 from Bacillus subtilis--the first temperature-dependent type I
toxin-antitoxin system. Molecular microbiology 2012, 83:579-598. 
27. Solecki O, Mosbah A, Baudy Floc'h M, Felden B: Converting a Staphylococcus aureus toxin into effective cyclic
pseudopeptide antibiotics. Chemistry & biology 2015, 22:329-335. 
28. Akimoto S, Ohnishi Y: R483 and F plasmid genes promoting RNA degradation: comparative restriction mapping.
Microbiology and immunology 1982, 26:779-793. 
29. Ono K, Akimoto S, Ohnishi Y: Nucleotide sequence of the pnd gene in plasmid R483 and role of the pnd gene
product in plasmolysis. Microbiology and immunology 1987, 31:1071-1083. 
30. Nielsen AK, Thorsted P, Thisted T, Wagner EG, Gerdes K: The rifampicin-inducible genes srnB from F and pnd
from R483 are regulated by antisense RNAs and mediate plasmid maintenance by killing of plasmid-free 
segregants. Molecular microbiology 1991, 5:1961-1973. 
31. Thisted T, Nielsen AK, Gerdes K: Mechanism of post-segregational killing: translation of Hok, SrnB and Pnd
mRNAs of plasmids R1, F and R483 is activated by 3'-end processing. The EMBO journal 1994, 13:1950-
1959. 
32. Fozo EM: New type I toxin-antitoxin families from "wild" and laboratory strains of E. coli: Ibs-Sib, ShoB-OhsC
and Zor-Orz. RNA biology 2012, 9:1504-1512. 
33. Kawano M, Reynolds AA, Miranda-Rios J, Storz G: Detection of 5'- and 3'-UTR-derived small RNAs and cis-
encoded antisense RNAs in Escherichia coli. Nucleic acids research 2005, 33:1040-1050. 
34. Koyanagi S, Levesque CM: Characterization of a Streptococcus mutans intergenic region containing a small toxic
peptide and its cis-encoded antisense small RNA antitoxin. PloS one 2013, 8:e54291. 
35. Durand S, Jahn N, Condon C, Brantl S: Type I toxin-antitoxin systems in Bacillus subtilis. RNA biology 2012,
9:1491-1497. 
36. Nicolas P, Mader U, Dervyn E, Rochat T, Leduc A, Pigeonneau N, Bidnenko E, Marchadier E, Hoebeke M, Aymerich
S, et al.: Condition-dependent transcriptome reveals high-level regulatory architecture in Bacillus subtilis. 
Science 2012, 335:1103-1106. 
37. Poulsen LK, Larsen NW, Molin S, Andersson P: A family of genes encoding a cell-killing function may be
conserved in all gram-negative bacteria. Molecular microbiology 1989, 3:1463-1472. 
38. Pedersen K, Gerdes K: Multiple hok genes on the chromosome of Escherichia coli. Molecular microbiology 1999,
32:1090-1102. 
39. Steinbrecher T, Prock S, Reichert J, Wadhwani P, Zimpfer B, Burck J, Berditsch M, Elstner M, Ulrich AS: Peptide-
lipid interactions of the stress-response peptide TisB that induces bacterial persistence. Biophysical journal 
2012, 103:1460-1469. 
40. Patel S, Weaver KE: Addiction toxin Fst has unique effects on chromosome segregation and cell division in
Enterococcus faecalis and Bacillus subtilis. Journal of bacteriology 2006, 188:5374-5384. 
41. Dintner S, Staron A, Berchtold E, Petri T, Mascher T, Gebhard S: Coevolution of ABC transporters and two-
component regulatory systems as resistance modules against antimicrobial peptides in Firmicutes 
Bacteria. Journal of bacteriology 2011, 193:3851-3862. 
42. Weaver KE: The par toxin-antitoxin system from Enterococcus faecalis plasmid pAD1 and its chromosomal
homologs. RNA biology 2012, 9:1498-1503. 
43●●. Michaux C, Hartke A, Martini C, Reiss S, Albrecht D, Budin-Verneuil A, Sanguinetti M, Engelmann S, Hain T, 
Verneuil N, et al.: Involvement of Enterococcus faecalis small RNAs in stress response and virulence. 
Infection and immunity 2014, 82:3599-3611.
This report that highlight the functions of certain candidate sRNAs in the adaptation of E. faecalis to 
environmental changes has shown that a mutant lacking an homolog of a toxin-antitoxin locus is 
hypervirulent and has increased abilities to colonize mice. 
44. Yamaguchi Y, Tokunaga N, Inouye M, Phadtare S: Characterization of LdrA (long direct repeat A) protein of
Escherichia coli. Journal of molecular microbiology and biotechnology 2014, 24:91-97. 
45. Fernandez De Henestrosa AR, Ogi T, Aoyagi S, Chafin D, Hayes JJ, Ohmori H, Woodgate R: Identification of
additional genes belonging to the LexA regulon in Escherichia coli. Molecular microbiology 2000, 35:1560-
1572. 
46. Sayed N, Nonin-Lecomte S, Rety S, Felden B: Functional and structural insights of a Staphylococcus aureus
apoptotic-like membrane peptide from a toxin-antitoxin module. The Journal of biological chemistry 2012, 
287:43454-43463. 
47. Coles M1, Djuranovic S, Söding J, Frickey T, Koretke K, Truffault V, Martin J, Lupas AN: AbrB-like
transcriptionfactors assume a swapped hairpin fold that is evolutionarily related to double-psi beta 
barrels. Structure 2005 Jun;13(6):919-28 
48. Kawano M: Divergently overlapping cis-encoded antisense RNA regulating toxin-antitoxin systems from E. coli:
hok/sok, ldr/rdl, symE/symR. RNA biology 2012, 9:1520-1527. 
49. Dufourc EJ, Buchoux S, Toupe J, Sani MA, Jean-Francois F, Khemtemourian L, Grelard A, Loudet-Courreges C,
Laguerre M, Elezgaray J, et al.: Membrane interacting peptides: from killers to helpers. Current protein & 
peptide science 2012, 13:620-631. 
50. Wessner F, Lacoux C, Goeders N, d'Herouel AF, Matos R, Serror P, Van Melderen L, Repoila F: Regulatory
crosstalk between type I and type II toxin-antitoxin systems in the human pathogen Enterococcus faecalis. 
RNA biology 2015:0. 
51. Ghafourian S, Raftari M, Sadeghifard N, Sekawi Z: Toxin-antitoxin Systems: Classification, Biological Function
and Application in Biotechnology. Current issues in molecular biology 2014, 16:9-14. 
52. Demidenok OI, Goncharenko AV: [Bacterial toxin-antitoxin systems and perspectives for their application in
medicine: a review]. Prikladnaia biokhimiia i mikrobiologiia 2013, 49:539-546. 
53. Mok WW, Li Y: A highly efficient molecular cloning platform that utilises a small bacterial toxin gene.
Chembiochem : a European journal of chemical biology 2013, 14:733-738. 
54. Booth JA, Suganthan R, Gaustad P, Bjoras M: Development of DinQ from Escherichia coli as an anti-cell-
envelope antibiotic. International journal of antimicrobial agents 2015, 45:196-197. 
1
 TA systems expressed in other bacteria and/or in other copies located in the bacterial genome. 
2
 Plasmid maintenance identified using plasmid other than the plasmid of origin expressing the TA locus.  
3 Biological functions identified when the TA systems are highly expressed using overexpression plasmids 
with endogenous or inducible promoters.  
4
 In vitro analysis with chemically synthesized peptides. 
5 The environmental conditions induce a modulation of the toxin mRNA expression in the wild-type strain. 
Class 
Type I toxin 
mechanisms 
of action 
Mechanisms 
of action 
discovered 
through: 
TA systems Locations Biological functions (discovered through:) Refs 
M
em
br
an
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so
ci
at
ed
 to
xi
ns
 
Pore formation 
Overexpression3 hok/Sok1 
- E. coli      
R1 plasmid 
- Numerous 
Gram- genomes 
- Plasmid maintenance (ectopic 
expression2) 
- Obg-mediated persistence (deletion) 
- Stress response to temperatures, 
antibiotics, SOS, etc. (ectopic 
expression2) 
[15] 
[16●●] 
[17●] 
Chemically 
synthesized4 tisB/IstR1
1
 
- E. coli 
chromosome 
- SOS-mediated persistence by inducing 
DNA repair and dormancy (deletion) [18-20] 
Nucleoid 
condensation 
Overexpression3 dinQ/AgrB - E. coli 
chromosome 
- SOS response (overexpression3) 
- Conjugal recombination (deletion) [21] 
Overexpression3 RNAI/RNAII1 - E. faecalis pAD1 plasmid 
- Plasmid maintenance (ectopic 
expression2) [22,23] 
Overexpression3 ldrD/RdlD1 - E. coli 
chromosome 
- Involved in purin metabolism and cAMP 
levels (overexpression3) 
[24] 
[25] 
Overexpression3 bsrG/SR41 - B. subtilis SPβ prophage - Unknown 
[14●●] 
[26] 
To be 
confirmed 
Chemically 
synthesized4 
sprA1/SprA1AS
1
-S. aureus 
ν∑αβ 
pathogenicity 
island 
- Acidic and oxidative stress responses 
(overexpression3) 
- Competing bacterial and human 
erythrocyte lysis (chemical synthesis4) 
[7] 
[27] 
Chemically 
synthesized4 sprG1/SprF1
1
 
- S. aureus 
SaPIn3 
pathogenicity 
island 
- Competing bacterial and human 
erythrocyte lysis (chemical synthesis4 and 
membrane extraction) 
[6•] 
pnd - E. coli R483 plasmid 
- Plasmid maintenance (ectopic 
expression2) 
[28] 
[29,30] 
srnB - E. coli F plasmid 
- Plasmid maintenance (ectopic 
expression2) 
[31] 
[30] 
ibsC/SibC1 - E. coli 
chromosome - Unknown [32] 
shoB/OhsC - E. coli 
chromosome 
- Heat and oxidative stress response 
(overexpression3) 
- Induction of carbohydrate transport 
expression (overexpression3) 
[33] 
[32] 
zorO/OrzO1 - E. coli 
chromosome - Unknown 
[4] 
[32] 
fst-Sm/SrSm1 - S. mutans 
chromosome 
- Inhibits persistence (mild-over 
expression2) [34] 
txpA/RatA1 
- B. subtilis   
skin phage-like 
element 
- Cell metabolic state? (endogenous5) 
[8] 
[35] 
[36] 
Cy
to
pl
as
m
ic
 
to
xi
ns
 RNA cleavage Overexpression3 symE/SymR1 - E. coli 
chromosome 
- SOS response (endogenous5) 
- Recycling damaged RNAs 
(overexpression3) 
[12] 
DNA cleavage Chemically 
synthesized4 ralR/RalA 
- E. coli 
rac prophage - Fosfomycin resistance (deletion) [13●] 
Toxin-encoding
mRNA translation
Toxic 
peptide
Pore membrane 
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Plasmid
External 
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↘ Membrane potential (PMF)
↘ Cellular energy levels
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E. faecalis
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Nucleic acid 
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Nucleoid 
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Unstable RNA antitoxin Stable toxin-encoding
mRNA
External 
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DNA
RNA
Stable toxin-encoding
mRNA translation
Plasmid
Membrane toxins Cytosolic toxins
